Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4

American Journal of Veterinary Research

Volumn 57, Issue 5, 1996, Pages 677-683

  Winter, Alexander J ^a   Schurig, Gerhardt G ^b   Boyle, Stephen M ^b   Sriranganathan, Nammalwar ^b   Bevins, Julia S ^c   Enright, Fred M ^d   Elzer, Philip H ^d   Kopec, John D ^e  

^a Department of Obstetrics Gynecology   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c UNIVERSITY OF ALASKA FAIRBANKS   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUCELLA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM MUTANT; BRUCELLA MELITENSIS; BRUCELLA SUIS; BRUCELLOSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; VACCINATION;

ALLELES; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BISON; BLOTTING, WESTERN; BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; CATTLE; DEER; FEMALE; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; MUTATION; REINDEER; RODENT DISEASES; SWINE; VACCINES, ATTENUATED;

ANIMALIA; BACTERIA (MICROORGANISMS); BISON; BRUCELLA; BRUCELLA MELITENSIS 16M; BRUCELLA MELITENSIS BIOVAR SUIS; CERVUS ELAPHUS; LISTERIA MONOCYTOGENES; OVIS; RANGIFER TARANDUS;

EID: 0029944247     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Blasco JM Brucella ovis. In. Nielsen K, Duncan JR, eds Animal brucellosis Boca Raton, Fla CRC Press, 1990;352-378
2. Brucellosis research an evaluation Report of the Subcommittee on Brucellosis Research, National Academy ol Sciences Washington, DC National Academy Press, 1977;61-77
3. Jimenez de Bagués MP, Marin CM, Blasco JM, et al. An ELISA with Brucclla lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B melitensis strain Rev 1 vaccination Vet Microbiol 1992;30:233-241.
4. Corner LA, Alton GG Persistence of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses Res Vet Sci 1981;31.342-344.
5. Jiménez de Bagués MP, Marin CM, Barberán M, et al Responses of ewes to B melitensis Rev 1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy Ann Rech Vet 1989,20:205-213.
6. Blasco JM, Diaz R Brucella melitensis Rev 1 as cause of human brucellosis. Lancet 1993,342 805.
7. Young EJ. Human brucellosis. Rev Inject Dis 1983,5.821-842
8. Afzal M, Tengerdy RP, Ellis RP, et al. Protection of rams against epididymitis by Brucella ovis-vitamin E adjuvant vaccine. Vet Immunol Immunopathol 1984,7:293-304.
9. Confer AW, Tabatabai LB, Deyoe BL, et al Vaccination of cattle with chemically modified and unmodified salt-extractable proteins from Brucella abortus. Vet Microbiol 1987;15:325-339.
10. McGowan B, Harold DR. Epididymitis in rams: studies on vaccine efficacy. Cornell Vet 1979;69:73-76.
11. Ray WC An assessment of investigations conducted in the USA on Brucella abortus strain 45/20 bacterins Dev Biol Stand 1975, 31:335-342
12. Cheville NF, Stevens MG, Jensen AE, et al. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am J Vet Res 1993;54:1591-1597.
13. Roop RM, Jeffers G, Bagchi T, et al Experimental infection of goat fetuses in utero with a stable, rough mutant of Brucella abortus. Res Vet Sci 1991;51.123-127.
14. Samartino LE, Enright FM. Interaction of bovine chorioallantoic membrane explants with three strains of Brucella abortus. Am J Vet Res 1992;53:359-363
15. Tobias L, Schurig GG, Cordes DO. Comparative behavior of Brucella abortus strains 19 and RB51 in the pregnant mouse. Res Vet Sci 1992;53:179-183.
16. Cheville NF, Jensen AE, Hailing SM, et al Bacterial survival, lymph node changes, and immunologie responses of cattle vaccinated with standard and mutant strains of Brucella abortus Am J Vet Res 1992,53:1881-1888.
17. Schurig GG, Roop RM, Bagchi T, et al. Biological properties of RB51, a stable rough strain of Brucella abortus. Vet Microbiol 1991, 28:171-188
18. Jiménez de Bagués MP, Elzer PH, Jones SM, et al. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Inject Immun 1994;62.4990-4996.
19. Alton GG Brucella melitensis. In: Nielsen K, Duncan JR, eds Animal brucellosis. Boca Raton, Fla: CRC Press, 1990,383-409.
20. Schurig GG, Hammerberg C, Finkler BR. Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex Am J Vet Res 1984;45.967-971.
21. Alton GG, Jones RD, Pietz DE. Laboratory techniques in brucellusis. 2nd ed, Geneva World Health Organization, 1975;37-39.
22. Montaraz JA, Winter AJ. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect Immun 1986; 53:245-251.
23. Moreno E, Pitt MW, Jones LM, et al. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol 1979;138.361-369.
24. Jiménez de Bagués MP, Elzer PH, Blasco JM, et al. Protective immunity against Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Inject Immun 1994;62:632-638
25. Elzer PH, Jacobson RH, Jones SM, et al. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology 1994;82:651-658
26. Tsang VCW, Wilson BC, Maddison SE Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay. Clin Chem 1980,26:1255-1260.
27. Winter AJ, Rowe GE, Duncan JR, et al Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice. Infect Immun 1988;56. 2808-2817.
28. Snedecor GW, Cochoran WG. Statistical methods. 8th ed Ames, Iowa: Iowa State University Press, 1989;53-58,98-99.
29. Winter AJ, Duncan JR, Santisteben CG, et al. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice Inject Immun 1989;57:3438-3444.
30. Araya LN, Elzer PH, Rowe GE, et al. Temporal development of protective cell mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol 1989;143:3330-3337.
31. Davis DS, Templeton JW, Ficht TA, et al. Brucella abortus in captive bison. I Serology, bacteriology, pathogenesis, and transmission to cattle J Wildl Dis 1990;26:360-371
32. Davis DS, Templeton JW, Ficht TA, et al. Brucelia abortus in bison. II. Evaluation of adult strain 19 vaccination. J Wildl Dis 1991;27:258-264.
33. Thome ET, Walthall TJ, Dawson HA. Vaccination of elk with strain 19 Brucella abortus. Proc 85th Annu Meet US Antm Health Assoc 1981,359-374.
34. Herriges JD Jr, Thorne ET, Anderson SL, et al. Vaccination of elk in Wyoming with reduced dose strain 19 Brucella. controlled studies and ballistic implant field trials. Proc 93rd Annu Meet US Antm Health Assoc 1989;640-645